Atisama Therapeutics said its lead candidate RB042 has advanced into multiple ascending dose cohorts in a…
Biotechnology News
Schrödinger Talks Platform Strategy at Bank of America Global Healthcare Conference 2026
Schrödinger presented at the Bank of America Global Healthcare Conference 2026, keeping attention on its hybrid…
MaxCyte Q1 2026 Earnings Call Transcript Highlights Commercial Platform Execution and Investor Focus
MaxCyte’s first-quarter 2026 earnings call provided a routine but important update on the cell-engineering company’s investor…
Rigel Pharmaceuticals Discusses VEPPANU Licensing Agreement on M&A Call
Rigel Pharmaceuticals held a conference call on May 12, 2026 to discuss a VEPPANU licensing agreement,…
IDEAYA Biosciences Discusses Strategy and Clinical Pipeline at Bank of America Healthcare Conference 2026
IDEAYA Biosciences participated in the Bank of America Global Healthcare Conference 2026, placing the clinical-stage biotech…